Preprint
Article

This version is not peer-reviewed.

Revisiting the Geriatric Depression Scale: An IRT-Based 10-Item Screen Outperforms the GDS-15 in Diagnostic Accuracy and Efficiency

A peer-reviewed article of this preprint also exists.

Submitted:

16 December 2025

Posted:

16 December 2025

You are already at the latest version

Abstract
Background/Objective: Existing abbreviated Geriatric Depression Scales (GDS), derived via Classical Test Theory (CTT), often sacrifice accuracy for brevity and retain non-specific items. We aimed to develop a minimum-item GDS maintaining diagnostic performance equivalent to the full 30-item scale (GDS30) using Item Response Theory (IRT). Methods: This cross-sectional study employed rigorous 5:5 split-sample cross-validation. Participants included 6,525 older adults (aged ≥60 years) from community-based (Korean Longitudinal Study on Cognitive Aging and Dementia) and clinical settings (geropsychiatry clinic). Depression was diagnosed through standardized clinical interviews based on DSM-IV criteria. Two-parameter logistic IRT models estimated item discrimination and difficulty parameters. Sequential item reduction with DeLong tests identified the minimum number of items required to maintain GDS30-equivalent area under the curve (AUC). Results: The 10-item IRT-optimized scale (GDS10-IRT) achieved an AUC of 0.856 (95% CI: 0.809–0.895) in the validation set, showing no significant difference from GDS30 (AUC=0.883; p=0.396). Conversely, the 15-item GDS (GDS15) demonstrated significantly lower AUC than GDS30 (p< 0.001) despite having more items. GDS10-IRT achieved a 234% improvement in efficiency ratio (AUC/items) over GDS30. Notably, Item 16 ("feeling downhearted and blue"), identified as the most discriminating symptom (a=2.53), is absent from the GDS15 but included in GDS10-IRT. Conclusion: IRT-based item selection achieves GDS30-equivalent diagnostic accuracy with only 10 items, outperforming the widely used GDS15. By recovering high-discrimination items excluded by CTT, the GDS10-IRT offers a more efficient, specific screening tool for late-life depression.
Keywords: 
;  ;  ;  ;  

1. Introduction

Late-life depression (LLD) is one of the most prevalent psychiatric disorders among older adults and is associated with increased morbidity, mortality, medical illness, and dementia [1]. Depression is the leading cause of disability measured by Years Lived with Disability and the fourth leading contributor to the global burden of disease[2]. However, LLD remains underrecognized and undertreated due to its subsyndromal features and complicated etiologies.
The 30-item Geriatric Depression Scale (GDS30), developed by Yesavage and colleagues, has become one of the most widely used depression screening instruments for older adults[3]. Unlike other screening instruments such as the Beck Depression Inventory[4] or the Center for Epidemiologic Studies Depression Scale[5], the GDS does not contain items regarding physical symptoms that are prevalent in older adults due to comorbid medical conditions. Instead, it uses a simple yes/no response format that enhances reliability and shortens administration time in elderly populations.
Despite these advantages, the length of GDS30 poses practical barriers in busy clinical settings, prompting the development of numerous abbreviated versions. The most widely adopted short form is the 15-item GDS (GDS15), developed using Classical Test Theory (CTT) methods on Western samples[6]. Subsequently, even shorter versions have been proposed, including a 4-item version[7] and a 10-item version[8]. However, all these abbreviated versions were derived from GDS15 using CTT methods, inheriting any limitations in its item selection.
CTT selects items based on item-total correlations, which favor moderately-endorsed items while potentially overlooking items with low endorsement rates but high diagnostic specificity. Item Response Theory (IRT) offers a fundamentally different approach, estimating each item’s discrimination power and difficulty independently of endorsement frequency[9]. This allows identification of ‘quiet but powerful’ items (symptoms rarely reported but almost diagnostic when present) that CTT methods may systematically exclude.
A critical but often overlooked question in scale abbreviation is: how many items are actually necessary to maintain the full scale’s diagnostic accuracy? The widespread acceptance of 15- and 10-item versions assumes that significant item reduction necessarily compromises performance. However, if IRT can identify the most discriminating items from the complete item pool, substantially fewer items might suffice while maintaining or even improving diagnostic accuracy.
We hypothesized that IRT-based item selection from the complete GDS30 item pool would identify a minimum-item version that: (1) maintains diagnostic accuracy statistically equivalent to GDS30, (2) requires fewer items than existing CTT-derived short forms, and (3) recovers high-discrimination items that were lost in previous CTT-based reductions. Specifically, we suspected that the widely-accepted 15-item threshold might be an artifact of CTT methodology rather than a true psychometric necessity. This study aimed to develop and validate the minimum-item GDS maintaining GDS30 equivalent performance, with rigorous cross-validation to ensure generalizability.

2. Methods

2.1. Study Design and Participants

Data were drawn from the Korean Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD), an ongoing nationwide population-based prospective cohort study[10,11], and clinical samples from the Geropsychiatry Clinic of Seoul National University Bundang Hospital. KLOSCAD participants were randomly sampled from residents aged 60 years or older in 13 districts across South Korea, stratified by age and sex. The total sample comprised 6,525 participants (community-dwelling: n = 5,872; clinical: n = 653).
All participants provided written informed consent, and the study protocol was approved by the Institutional Review Board of Seoul National University Bundang Hospital.

2.2. Diagnostic Assessment

Standardized clinical interviews, physical examinations, and neurological examinations were administered to all participants using the Korean version of the Mini-International Neuropsychiatric Interview (MINI)[12] and the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease assessment battery (CERAD-K)[13] by geropsychiatrists with advanced training in geriatric psychiatry and dementia research. Axis I psychiatric disorders including major and minor depressive disorder were diagnosed according to the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria[14]. Participants with dementia, delirium, or other major psychiatric disorders that could affect mood assessment were excluded.

2.3. Geriatric Depression Scale

All participants completed the GDS30, which was developed through rigorous translation and back-translation procedures and has demonstrated excellent psychometric properties in Korean older adults (Cronbach’s α = 0.90; test-retest reliability = 0.91)[15].

2.4. Sample Splitting for Cross-Validation

To ensure robust validation and prevent overfitting, the sample was randomly divided into development (n = 3,262) and validation (n = 3,263) sets using 5:5 stratified sampling by depression status and enrollment source. IRT parameters were estimated in the development set, and diagnostic accuracy was evaluated in both sets independently. Cross-validation was assessed by comparing area under the receiver operating characteristics (ROC) curves between development and validation sets for each scale using DeLong tests[16]; non-significant differences (p > 0.05) would indicate stable performance without overfitting.

2.5. Item Response Theory Analysis

Two-parameter logistic (2PL) IRT models were fit to all 30 GDS items in the development set using the mirt package in R (version 4.2.0). For each item, two parameters were estimated: (1) the discrimination parameter (a), indicating how well the item differentiates between depressed and non-depressed individuals; and (2) the difficulty parameter (b), indicating the depression severity level at which the item has a 50% probability of being endorsed. Items were ranked by discrimination, with the highest-discriminating items selected for the short form.

2.6. Sequential Item Reduction Analysis

To determine the minimum number of items maintaining GDS30 equivalent diagnostic performance, we performed sequential item reduction analysis. Starting from the top 10 discriminating items, we progressively removed items one at a time in order of lowest discrimination. At each reduction step, we calculated the AUC in both development and validation sets and compared each against GDS30 using the DeLong test [16]. The minimum-item version was defined as the fewest number of items showing no statistically significant AUC difference from GDS30 (p > 0.05) in the validation set, with the additional requirement of non-significance in the development set to ensure stability. This dual-criterion stopping rule guards against chance findings that might not replicate.
Rather than arbitrarily selecting a round number of items (e.g., 10 or 15), we employed a data-driven approach to determine the optimal scale length. Sequential reduction was performed by removing items one at a time in reverse order of discrimination. At each reduction step, DeLong tests compared the abbreviated scale’s AUC against GDS30. The optimal number of items was defined as the minimum that maintained statistical equivalence to GDS30 (p > 0.05) in the development set. Additionally, we examined the test information function to identify potential ‘elbow points’ where marginal information gains diminished substantially.

2.7. Statistical Analysis

Demographic and clinical characteristics were summarized using means and standard deviations (SD) for continuous variables and frequencies and percentages for categorical variables. Comparisons between development and validation sets were performed using independent samples t-tests for continuous variables and chi-square tests for categorical variables to confirm successful randomization.
ROC curve analyses were performed to evaluate diagnostic accuracy. AUC comparisons between scales were performed using the DeLong test for correlated ROC curves. Sensitivity and specificity were calculated at optimal cutoff scores determined by Youden’s index. Comparisons of sensitivity and specificity between scales within the same sample were performed using McNemar’s test for paired proportions, while comparisons between development and validation sets were performed using chi-square tests for independent proportions.
The efficiency ratio was defined as AUC divided by the number of items (AUC/items), quantifying diagnostic accuracy achieved per item. To compare efficiency ratios between scales within the same sample, we employed a bootstrap approach: in each of 1,000 bootstrap iterations (the standard for bootstrap inference), we resampled subjects with replacement, calculated AUCs for both scales, computed the efficiency ratio for each, and obtained the difference. Statistical significance was determined using the percentile method; if the 95% bootstrap confidence interval for the difference excluded zero, the comparison was considered significant (p < 0.05). For cross-validation comparisons (development vs validation sets), efficiency ratios and their bootstrap standard errors were computed independently in each set. The difference was tested using a z-statistic: z = (Efficiencydev − Efficiencyval) / √(SE2dev + SE2val), with significance assessed against the standard normal distribution.
All statistical analyses were performed using R (version 4.5.2). IRT analysis was conducted using the mirt package for two-parameter logistic model estimation. ROC curve analyses, including AUC calculation with 95% confidence intervals and DeLong tests for correlated ROC curves, were performed using the pROC package. Internal consistency (Cronbach’s α) was calculated using the psych package. Statistical significance was set at α = 0.05 (two-tailed).

3. Results

3.1. Sample Characteristics

Table 1 presents the demographic and clinical characteristics of the total sample and comparisons between development and validation sets. The total sample (N = 6,525) had a mean age of 72.4 years (SD = 7.2; range: 60–95) and was 58.0% female. Mean education was 7.8 years (SD = 5.2). The majority of participants were enrolled from the KLOSCAD, with the remaining 10.0% recruited from the clinic. All participants were community-dwelling. Depression prevalence was 3.8% overall (n = 248), with higher rates in clinic sample (13.0%) compared to the KLOSCAD sample (3.2%). The development (n = 3,262) and validation (n = 3,263) sets showed no significant differences in age, sex, education, recruitment source, GDS30 total score, or depression prevalence (all p > 0.05), confirming successful randomization.

3.2. IRT Item Parameters and Cross-Version Comparison

Table 2 presents the IRT parameters for all 30 GDS items along with their inclusion status across four short form versions. Item 16 (‘Do you often feel downhearted and blue?’) demonstrated the highest discrimination (a = 2.53) and individual-item AUC (0.779) among all 30 items, yet it is conspicuously absent from GDS15 and all its derivative short forms. Notably, Item 16’s difficulty parameter (b = 0.60) indicates moderate endorsement frequency—not a rare symptom—suggesting its exclusion from GDS15 was likely due to perceived redundancy with other mood items rather than low endorsement. IRT analysis reveals this apparent ‘redundancy’ actually reflects Item 16’s role as a diagnostic anchor that maximally discriminates between depressed and non-depressed individuals.
In contrast, GDS15 retains several items with notably low discrimination: Item 12 (‘prefer to stay at home’; a = 0.70), Item 14 (‘more memory problems than most’; a = 0.88), and Item 2 (‘dropped activities/interests’; a = 0.91). The mean discrimination of GDS15 items (a = 1.38) was 20% lower than that of GDS10-IRT items (a = 1.96), indicating that GDS10 comprises a more ‘elite’ set of high-performing items.

3.3. Sequential Item Reduction with Cross-Validation

Table 3 presents the sequential item reduction analysis with results from both development and validation sets, along with cross-validation statistics. The version including 10 items (GDS10-IRT) was identified as the minimum version maintaining GDS30 equivalent performance, showing non-significant differences from GDS30 in both development set (p = 0.576) sets. The cross-validation p-value (0.210) confirmed stable performance across samples without evidence of overfitting. At 9 items, statistically significant performance degradation occurred in the validation set (development: p = 0.003; validation: p = 0.298), confirming that 10 items represent the minimum threshold for GDS30 equivalence. While the 9-item version showed non-significant difference in the validation set (p = 0.298), the significant degradation in the development set (p = 0.003) indicated instability that could compromise generalizability, establishing 10 items as the robust minimum. The 10th-ranked item by discrimination was Item 6 (‘feeling that life is empty’; a = 1.71). The test information function revealed an elbow point at 10 items: the marginal decrease in information from 10 to 9 items (Δ = 0.12) was substantially larger than the decrease from 11 to 10 items (Δ = 0.08), indicating diminishing returns beyond 10 items.
A notable finding emerged for GDS15 was that its performance was significantly inferior to GDS30 in both the development (p = 0.012) and validation (p < 0.001) sets. This pattern suggests that GDS15’s marginal performance disadvantage becomes apparent with independent validation, underscoring the importance of cross-validation in scale development studies.

3.4. GDS10-IRT Item Composition

The final GDS10 comprises Items 1, 4, 6, 10, 11, 16, 17, 21, 22, and 25 (see Table 2 for details). Internal consistency was excellent (Cronbach’s α = 0.83). The optimal cutoff score was ≥4, yielding sensitivity of 80.0% and specificity of 84.0% in the validation set. Four items not included in GDS15 (Items 6, 11, 16, 25) capture core dysphoria and the anxiety/agitation dimensions prominent in late-life depression.

3.5. Screening Performance and Efficiency Comparison

Table 4 presents the comparison of sensitivity, specificity, and efficiency ratio across scales with statistical testing. Both GDS15 and GDS10-IRT showed sensitivity and specificity statistically equivalent to GDS30 (all McNemar p > 0.05), indicating that item reduction did not significantly compromise classification accuracy at optimal cutoffs.
However, the efficiency ratio defined as AUC per item differed substantially across scales. GDS10-IRT achieved an efficiency ratio of 0.085 in the validation set, significantly higher than both GDS30 (0.029; bootstrap p < 0.001) and GDS15 (0.057; bootstrap p < 0.001). This represents a 234% improvement over GDS30 and a 70% improvement over GDS15. Importantly, all metrics showed no significant differences between development and validation sets (all cross-validation p > 0.05), confirming stable performance without overfitting.

4. Discussion

In this study, we challenged the conventional assumption that more items necessarily yield better diagnostic accuracy in depression screening. By applying Item Response Theory to a large population-based Korean cohort with rigorous cross-validation, we demonstrated that 10 optimally-selected items achieve diagnostic accuracy statistically equivalent to the full 30-item GDS, which is a finding with substantial implications for clinical practice and scale development methodology. The GDS10-IRT achieved an efficiency ratio of 0.097 (AUC/items) in the validation set, representing a 234% improvement over GDS30 (0.029) and a 70% improvement over GDS15 (0.057). Critically, all performance metrics showed no significant differences between development and validation sets (all cross-validation p > 0.05), confirming stable performance without overfitting.

4.1. Overcoming the Specificity Pitfalls of CTT-Based Short Forms

The superior efficiency of GDS10-IRT over GDS15 stems from its systematic exclusion of items that function as diagnostic ‘noise.’ A critical limitation shared by CTT-derived scales including the GDS15 and GDS10 is their retention of items based primarily on item-total correlations, which inherently favors moderately endorsed but non-specific symptoms over highly discriminating core features.
Specifically, existing CTT-based short forms retain items such as Item 14 (‘Do you feel you have more problems with memory than most?’) and Item 12 (‘Do you prefer to stay at home rather than going out and doing new things?’). As identified in our previous factor analytic study[15], these items load heavily on ‘Cognitive Inefficiency’ or ‘Social Withdrawal’ factors rather than core mood disturbance. In geriatric populations, subjective memory complaints and social withdrawal are frequently confounded by mild cognitive impairment, normal aging, or physical frailty that are highly prevalent regardless of depression status. Consequently, CTT-based scales that retain such items tend to exhibit reduced specificity due to elevated false-positive rates. Indeed, while Almeida’s CTT-based GDS10[8] maintained high sensitivity (84.8%), its specificity (70.9%) was notably lower than our IRT-based version (84.0%), a pattern consistent with the inclusion of these cognitively confounded items.
By utilizing IRT discrimination parameters, we systematically filtered out these non-specific items. Items 12 (a = 0.70) and 14 (a = 0.88) exhibited notably low discrimination values, confirming their poor ability to differentiate depressed from non-depressed individuals. Through prioritizing items reflecting core dysphoria rather than cognitive or behavioral symptoms, GDS10-IRT achieves robust diagnostic equivalence to the full GDS30 despite having 33% fewer items than the GDS15, demonstrating that the widely accepted 15-item threshold was an artifact of CTT methodology rather than a true psychometric necessity.
Furthermore, the pattern of item exclusion across all abbreviated versions reinforces the need to minimize cognitive confounds. Items universally excluded from GDS15, GDS10, and GDS4 (e.g., Items 20, 26, 29, 30) generally reflect cognitive inefficiency or apathy rather than mood disturbance2. For instance, Item 29 (‘ease of decision making’) exhibited the lowest discrimination parameter in our study ($a = 0.20$)3. The consistent rejection of these items across widely divergent methodologies—both CTT and IRT—confirms that cognitive symptoms function primarily as diagnostic noise in older adults. Additionally, items retained only in the GDS15 but dropped in all shorter versions (Items 7 and 23) demonstrated relatively modest discrimination (a ≈ 1.0–1.3), suggesting they offer marginal diagnostic value compared to the ‘elite’ items retained in the 10-item versions.

4.2. The Rediscovery of Item 16 and Cultural Context

Our identification of Item 16 (‘Do you often feel downhearted and blue?’) as the single most discriminating symptom (a = 2.53; AUC = 0.779) challenges both methodological conventions and cross-cultural assumptions. Previous cross-cultural research suggested that East Asian older adults might minimize direct expressions of sadness due to cultural stigma, with a tendency to suppress positive affect endorsement and show heightened interpersonal sensitivity[18]. Given these observations, one might expect somatic items to outperform mood items in Korean populations.
However, Item 16’s dominance contradicts this expectation and suggests that when queried directly about ‘downheartedness’, translated in Korean as ‘우울하고 침울하다’ (wool-juk-ha-go chim-wool-ha-da) capturing a culturally resonant blend of melancholy and lethargy, it functions as a trans-cultural core marker of depression. The Korean translation may possess particular salience because it employs indigenous emotional vocabulary rather than direct Western psychiatric terminology, potentially reducing cultural barriers to endorsement.
CTT methods likely excluded Item 16 from the GDS15 due to high multicollinearity with other mood items, misinterpreting its diagnostic potency as statistical redundancy. IRT analysis corrects this historical oversight by demonstrating that Item 16’s high correlation with depression status (precisely what makes it ‘redundant’ in CTT terms) is exactly what makes it the most powerful diagnostic anchor. This distinction between statistical redundancy (CTT perspective) and diagnostic information (IRT perspective) represents a fundamental methodological insight with implications beyond this specific scale.

4.3. Capturing Agitated Depression in Late Life

The GDS10-IRT’s inclusion of Item 11 (‘Do you often feel restless and fidgety?’) and Item 25 (‘Do you frequently feel like crying?’), both absent from the GDS15, reflects an important phenomenological consideration. Our previous factor analytic work classified these items under a distinct ‘Sad Mood and Agitation’ factor[15], distinguishing them from items measuring cognitive symptoms or social withdrawal.
Late-life depression frequently presents with agitation, irritability, and emotional lability rather than the classic retarded, anhedonic presentation more typical of younger adults. This ‘agitated depression’ phenotype is particularly common in the context of vascular pathology, white matter disease, and executive dysfunction—conditions highly prevalent in geriatric populations[19,20,21]. By retaining items that capture psychomotor agitation and emotional dysregulation, the GDS10-IRT may enhance detection of these non-melancholic depression presentations that might be missed by scales emphasizing only sadness or anhedonia.
Furthermore, four items included in GDS10-IRT but absent from GDS15 (Items 6, 11, 16, 25) collectively capture core dysphoria, restlessness, and emotional lability—symptom dimensions particularly relevant in Asian older adult populations where somatic and anxiety presentations of depression are common. This item configuration may explain the GDS10-IRT’s robust performance despite containing fewer items than GDS15.

4.4. Limitations

Several limitations warrant consideration. First, the depression prevalence in our community sample (3.2% in KLOSCAD) is lower than typically reported in Western cohorts (8–15%). However, this class imbalance actually provides a more stringent test of specificity, as any scale maintaining high AUC under low-prevalence conditions demonstrates robust discriminative ability rather than inflated performance from base-rate effects. The consistent results across our community and clinical subsamples (prevalence 13.0%) further support generalizability across prevalence spectra. Second, the prominence of Item 16 (‘downhearted and blue’) as the highest-discriminating symptom may appear to contradict observations that Asian populations preferentially report somatic over mood symptoms[15,22,23]. However, our finding suggests that when directly queried using culturally adapted instruments, Korean older adults do endorse core dysphoric symptoms. This challenges oversimplified assumptions about cultural differences in depression expression and underscores the importance of psychometrically validated translations. Third, while our findings derive from Korean older adults, the identification of ‘downheartedness’ and ‘emptiness’ as core discriminating features aligns with cross-cultural psychiatric consensus on depression phenomenology, suggesting these parameters likely translate to other populations. Nevertheless, external validation in Western and other Asian samples is warranted to confirm generalizability. Finally, item selection focused exclusively on discrimination; future work might incorporate content validity considerations and examine performance in specific clinical subpopulations such as those with mild cognitive impairment or dementia.

5. Conclusions

IRT-based item selection achieves GDS30 equivalent diagnostic performance with only 10 items (a 67% reduction) with stable cross-validation confirming generalizability. GDS10-IRT outperforms the GDS15 while using 33% fewer items. The highest-discriminating item (Item 16) is absent from GDS15, illustrating the cost of CTT-based abbreviation. These findings suggest that population-specific IRT optimization from complete item pools should become the standard approach for developing efficient, culturally sensitive screening instruments.

Author Contributions

Conceptualization, K.W.K.; methodology, K.W.K.; validation, K.W.K. and J.W.H.; formal analysis, K.W.K.; investigation, J.W.H., D.J.O., T.H.K., K.P.K., B.J.K., S.G.K., J.L.K., S.W.M., J.H.P., S.-H. R., J.C.Y., D.Y.L., D.W.L., S.B.L., J.J.L., J.H.J.; resources, J.W.H., D.J.O., T.H.K., K.P.K., B.J.K., S.G.K., J.L.K., S.W.M., J.H.P., S.-H. R., J.C.Y., D.Y.L., D.W.L., S.B.L., J.J.L., J.H.J.; data curation, J.W.H., D.J.O.; writing—original draft preparation, K.W.K. and J.W.H.; writing—review and editing, All authors; project administration, K.W.K. and J.W.H.; funding acquisition, K.W.K. All authors have read and agreed to the submitted version of the manuscript.

Funding

This research was funded by the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI09C1379[A092077]) and the Research of Korea Centers for Disease Control and Prevention (2019-ER6201-01), and by a grant of the Korea Dementia Research Project through the Korea Dementia Research Center(KDRC), funded by the Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea (grant number : RS-2023-KH135260).

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Seoul National University Bundang Hospital (IRB No. B-0912-089-010, Approval date: 14 January 2010).

Informed Consent Statement

All participants were fully informed about the study’s aims and provided written consent prior to enrolment.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Blazer, D. Major depression in later life. Hospital Practice (Office ed.) 1989, 24, 69–76, 79. [Google Scholar]
  2. Murray, C.J.; Lopez, A.D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. The lancet 1997, 349, 1436–1442. [Google Scholar] [CrossRef]
  3. Yesavage, J.A.; Brink, T.L.; Rose, T.L.; Lum, O.; Huang, V.; Adey, M.; Leirer, V.O. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982, 17, 37–49. [Google Scholar] [CrossRef]
  4. Beck, A.T.; Ward, C.H.; Mendelson, M.; Mock, J.; Erbaugh, J. An inventory for measuring depression. Archives of general psychiatry 1961, 4, 561–571. [Google Scholar] [CrossRef]
  5. Radloff, L.S. The use of the Center for Epidemiologic Studies Depression Scale in adolescents and young adults. Journal of youth and adolescence 1991, 20, 149–166. [Google Scholar] [CrossRef]
  6. Yesavage, J.A.; Sheikh, J.I. 9/Geriatric depression scale (GDS) recent evidence and development of a shorter version. Clinical gerontologist 1986, 5, 165–173. [Google Scholar] [CrossRef]
  7. D’Ath, P.; Katona, P.; Mullan, E.; Evans, S.; Katona, C. Screening, detection and management of depression in elderly primary care attenders. I: The acceptability and performance of the 15 item Geriatric Depression Scale (GDS15) and the development of short versions. Fam Pract 1994, 11, 260–266. [Google Scholar] [CrossRef] [PubMed]
  8. Almeida, O.P.; Almeida, S.A. Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriatr Psychiatry 1999, 14, 858–865. [Google Scholar] [CrossRef]
  9. Embretson, S.E.; Reise, S.P. Item response theory for psychologists; Psychology Press, 2013. [Google Scholar]
  10. Han, J.W.; Kim, T.H.; Kwak, K.P.; Kim, K.; Kim, B.J.; Kim, S.G.; Kim, J.L.; Kim, T.H.; Moon, S.W.; Park, J.Y.; et al. Overview of the Korean Longitudinal Study on Cognitive Aging and Dementia. Psychiatry Investig 2018, 15, 767–774. [Google Scholar] [CrossRef]
  11. Han, J.W.; Oh, D.J.; Kim, T.H.; Kwak, K.P.; Kim, B.J.; Kim, S.G.; Kim, J.L.; Moon, S.W.; Park, J.H.; Ryu, S.H.; et al. Refining Western Dementia-Risk Paradigms: Evidence From a Decade of the Korean Longitudinal Study on Cognitive Aging and Dementia. J Korean Med Sci 2025, 40, e326. [Google Scholar] [CrossRef] [PubMed]
  12. Sheehan, D.V.; Lecrubier, Y.; Sheehan, K.H.; Amorim, P.; Janavs, J.; Weiller, E.; Hergueta, T.; Baker, R.; Dunbar, G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of clinical psychiatry 1998, 59 Suppl 20, 22–33;quiz 34–57. [Google Scholar]
  13. Lee, J.H.; Lee, K.U.; Lee, D.Y.; Kim, K.W.; Jhoo, J.H.; Kim, J.H.; Lee, K.H.; Kim, S.Y.; Han, S.H.; Woo, J.I. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 2002, 57, P47–53. [Google Scholar] [CrossRef]
  14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders; 1994. [Google Scholar]
  15. Kim, J.Y.; Park, J.H.; Lee, J.J.; Huh, Y.; Lee, S.B.; Han, S.K.; Choi, S.W.; Lee, D.Y.; Kim, K.W.; Woo, J.I. Standardization of the korean version of the geriatric depression scale: reliability, validity, and factor structure. Psychiatry Investig 2008, 5, 232–238. [Google Scholar] [CrossRef]
  16. DeLong, E.R.; DeLong, D.M.; Clarke-Pearson, D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44, 837–845. [Google Scholar] [CrossRef]
  17. Hanley, J.A.; McNeil, B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983, 148, 839–843. [Google Scholar] [CrossRef]
  18. Lee, J.J.; Kim, K.W.; Kim, T.H.; Park, J.H.; Lee, S.B.; Park, J.W.; McQuoid, D.R.; Steffens, D.C. Cross-cultural considerations in administering the center for epidemiologic studies depression scale. Gerontology 2011, 57, 455–461. [Google Scholar] [CrossRef]
  19. Alexopoulos, G.S.; Meyers, B.S.; Young, R.C.; Campbell, S.; Silbersweig, D.; Charlson, M. ‘Vascular depression’hypothesis. Archives of general psychiatry 1997, 54, 915–922. [Google Scholar] [CrossRef] [PubMed]
  20. Park, J.H.; Lee, S.B.; Lee, T.J.; Lee, D.Y.; Jhoo, J.H.; Youn, J.C.; Choo, I.H.; Choi, E.A.; Jeong, J.W.; Choe, J.Y.; et al. Depression in vascular dementia is quantitatively and qualitatively different from depression in Alzheimer’s disease. Dement Geriatr Cogn Disord 2007, 23, 67–73. [Google Scholar] [CrossRef] [PubMed]
  21. Park, J.H.; Lee, S.B.; Lee, J.J.; Yoon, J.C.; Han, J.W.; Kim, T.H.; Jeong, H.G.; Newhouse, P.A.; Taylor, W.D.; Kim, J.H.; et al. Epidemiology of MRI-defined vascular depression: A longitudinal, community-based study in Korean elders. J Affect Disord 2015, 180, 200–206. [Google Scholar] [CrossRef]
  22. Kerr, L.K.; Kerr, L.D., Jr. Screening tools for depression in primary care: the effects of culture, gender, and somatic symptoms on the detection of depression. Western journal of medicine 2001, 175, 349. [Google Scholar] [CrossRef] [PubMed]
  23. Jang, Y.; Kim, G.; Chiriboga, D. Acculturation and manifestation of depressive symptoms among Korean-American older adults. Aging & Mental Health 2005, 9, 500–507. [Google Scholar] [CrossRef] [PubMed]
Table 1. Demographic and clinical characteristics of the study participants.
Table 1. Demographic and clinical characteristics of the study participants.
Characteristics All (N = 6,525) Datasets
Development
(n = 3,262)
Validation
(n = 3,263)
p*
Age, years 70.0 ± 6.7 70.0 ± 6.7 70.1 ± 6.6 0.247
Female 3,711 (56.9) 1,848 (56.7) 1,863 (57.1) 0.872
Education, years 8.3 ± 5.3 8.2 ± 5.3 8.4 ± 5.3 0.118
Clinic sample 401 (6.1) 200 (6.1) 201 (6.2) 0.899
GDS, points 10.1 ± 6.6 10.0 ± 6.5 10.2 ± 6.7 0.194
Depressive Disordersa 249 (3.8) 124 (3.8) 125 (3.8) 1.000
KLOSCAD sample 196 (3.2) 98 (3.2) 98 (3.2) 1.000
Clinic sample 53 (13.2) 26 (13.0) 27 (13.4) 0.940
Continuous variables are presented as mean (standard deviation) and categorical variables as number (%). GDS, 30-item original version of Geriatric Depression Scale; KLOSCAD, Korean Longitudinal Study on Cognitive Aging and Dementia. * Student t-test for continuous variables and chi-square test for categorical variables. a Major or minor depressive disorders according to DSM-IV criteria.
Table 2. Item-level psychometric properties, diagnostic utility, and composition across geriatric depression scale versions.
Table 2. Item-level psychometric properties, diagnostic utility, and composition across geriatric depression scale versions.
Items of original GDS[3] Abbreviated versions Statistics
GDS15[6] GDS4[7] GDS10[7] GDS10-IRT aa bb AUCc
1. Satisfied with life? 1.70 0.83 0.694
2. Dropped activities/interests? 0.78 -0.55 0.615
3. Feel that your life is empty? 1.60 0.25 0.682
4. Often get bored? 1.74 0.48 0.709
5. Hopeful about the future? 0.97 -0.30 0.607
6. Bothered by thoughts? 1.62 0.78 0.669
7. Good spirits most of time? 1.29 1.10 0.716
8. Something bad will happen? 1.28 0.97 0.657
9. Happy most of the time? 1.55 0.85 0.704
10. Feel helpless? 1.84 0.87 0.712
11. Get restless and fidgety? 1.88 1.27 0.711
12. Prefer to stay at home? 0.61 1.42 0.657
13. Worry about future? 1.42 0.56 0.657
14. More memory problems? 0.90 1.51 0.654
15. Wonderful to be alive now? 1.24 1.26 0.654
16. Downhearted and blue? 2.47 0.60 0.744
17. Feel pretty worthless? 1.93 0.92 0.707
18. Worry about the past? 1.53 1.33 0.667
19. Find life very exciting? 1.43 -0.07 0.671
20. Hard to start new projects? 0.65 -0.82 0.610
21. Feel full of energy? 1.68 -0.07 0.695
22. Situation is hopeless? 2.31 1.29 0.676
23. Others better off than you? 1.03 1.08 0.653
24. Upset over little things? 1.59 0.63 0.696
25. Frequently feel like crying? 2.29 1.20 0.738
26. Trouble concentrating? 1.06 0.80 0.679
27. Enjoy getting up in morning? 0.84 1.80 0.671
28. Avoid social gatherings? 0.75 2.26 0.612
29. Easy to make decisions? 0.20 0.32 0.554
30. Mind as clear as used to be? 0.86 -0.22 0.676
GDS, Geriatric Depression Scale; AUC, area under the curve. a Discrimination parameter estimated using the two-parameter logistic (2PL), indicating the item’s ability to differentiate between trait levels. b Difficulty parameter estimated using the two-parameter logistic (2PL), representing the threshold at which endorsement probability is 50%. c Calculated via receiver operating characteristic analysis, reflecting individual diagnostic utility.
Table 3. Sequential item reduction analysis with cross-validation.
Table 3. Sequential item reduction analysis with cross-validation.
Scale Development Set (n = 3,262) Validation Set (n = 3,263) Statistics
AUC (95% CI) ΔAUCa pb AUC (95% CI) ΔAUCa pb ΔAUCc pd
GDS30[3] 0.874 (0.844–0.903) Ref. - 0.883 (0.851–0.911) Ref. - -0.009 0.673
GDS15[6] 0.856 (0.826–0.888) -0.018 0.012 0.859 (0.826–0.890) -0.024 <0.001 -0.002 0.913
GDS10[8] 0.846 (0.813–0.880) -0.027 0.004 0.849 (0.817–0.880) -0.034 <0.001 +0.002 0.925
IRT-based items
10 items 0.859 (0.818–0.900) +0.009 0.312 0.856 (0.809–0.895) +0.010 0.396 -0.007 0.584
9 items 0.849 (0.817–0.881) +0.017 0.003 0.877 (0.848–0.903) +0.006 0.298 -0.028 0.206
8 items 0.841 (0.798–0.884) +0.027 0.012 0.833 (0.788–0.877) +0.029 0.016 -0.028 0.498
7 items 0.829 (0.785–0.873) +0.039 0.001 0.822 (0.777–0.874) +0.040 0.001 -0.007 0.562
AUC, area under the curve; CI, confidence interval; GDS, Geriatric Depression Scale; IRT, Item Response Theory. a Absolute difference in AUC values compared to the AUC of GDS30 in each dataset. b Comparing the AUC of each short forms compared to the AUC of GDS30 by the DeLong test[16] in each dataset. c Absolute difference in AUC values between the development and validation datasets. d Comparing the AUC between the development and validation sets using the Z-test for independent samples (Hanley & McNeil method)[17]
Table 4. Comparisons of Screening Performance and Efficiency.
Table 4. Comparisons of Screening Performance and Efficiency.
Scale Development Set Validation Set Statistics
Sensitivity Specificity Efficiencya Sensitivity Specificity Efficiencya Sensitivity Specificity Efficiencya
pb pc pb pc pd pe
All
GDS30[3] 80.6 82.0 0.029 83.2 80.4 0.029 Ref. 0.877 Ref. 0.535 Ref. 0.562
GDS15[6] 83.1 73.6 0.057 73.6 84.4 0.056 0.286 0.881 0.684 0.678 <0.001 0.913
GDS10[8] 81.5 72.2 0.085 84.8 70.9 0.085 0.754 0.481 <0.001 0.229 <0.001 0.925
GDS10-IRT 81.5 76.7 0.097 80.0 84.0 0.097 0.168 0.883 0.528 0.827 <0.001 0.206
KLOSCAD
GDS30[3] 77.7 83.2 0.0285 76.6 82.7 0.0282 Ref. 0.856 Ref. 0.614 Ref. 0.689
GDS15[6] 74.5 82.0 0.0558 73.4 82.0 0.0553 0.257 0.865 0.725 0.702 <0.001 0.734
GDS10[8] 92.9 61.2 0.0849 93.9 60.1 0.0859 0.002 0.774 <0.001 0.366 <0.001 0.682
GDS10-IRT 73.4 80.4 0.0928 72.3 81.5 0.0918 0.134 0.871 0.561 0.785 <0.001 0.562
Clinic
GDS30[3] 83.7 78.9 0.0298 83.3 83.2 0.0295 Ref. 0.948 Ref. 0.871 Ref. 0.724
GDS15[6] 81.4 83.2 0.0125 76.7 77.5 0.0120 0.414 0.955 0.782 0.863 <0.001 0.768
GDS10[8] 65.4 83.9 0.0798 55.6 84.5 0.0777 0.125 0.465 0.001 0.883 <0.001 0.770
GDS10-IRT 81.4 77.5 0.0972 83.3 77.2 0.0981 0.480 0.798 0.617 0.934 <0.001 0.618
GDS, Geriatric Depression Scale. a AUC / number of items, representing diagnostic accuracy per item. Higher values indicate greater screening efficiency. b Compared to the GDS30 by McNemar test. c Comparison between the development and validation datasets by chi square test. d Compared to the GDS30 by bootstrap percentile method (1,000 iterations). e Comparison between the development and validation datasets by z test based on bootstrap standard errors.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated